These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7690090)

  • 21. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
    Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
    Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of the new calcium antagonist lacidipine.
    Kawada T; Sun HT; Nakazawa M; Imai S
    Jpn J Pharmacol; 1993 Jul; 62(3):289-96. PubMed ID: 8411776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression.
    Buljubasic N; Marijic J; Stowe DF; Gross GJ; Kampine JP; Bosnjak ZJ
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):594-604. PubMed ID: 1724538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity.
    Nagura J; Murayama B; Harada N; Suzuki K; Miyano T; Yajima M; Takeya K
    Jpn J Pharmacol; 1986 Mar; 40(3):399-409. PubMed ID: 3712868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146) in the cardiovascular system.
    Kogi K; Uchibori T; Aihara K; Yamaguchi T; Abiru T
    Jpn J Pharmacol; 1991 Oct; 57(2):153-65. PubMed ID: 1812297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D; Roy F; Brown NL
    Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
    Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
    Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
    Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative selectivity for negative chronotropic and inotropic effects of a novel dihydropyridine derivative CD-832.
    Noguchi K; Masumiya H; Sasaki T; Takahashi K; Araki H; Higuchi S; Tanaka H; Shigenobu K
    Eur J Pharmacol; 1996 Jul; 308(1):53-9. PubMed ID: 8836632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
    Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
    Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
    Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of palonidipine hydrochloride (TC-81), a novel calcium antagonist, on the canine coronary artery].
    Okamiya Y; Kishimoto T; Aoki K; Sunakawa K; Hoshina K; Takeshita T
    Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):23-33. PubMed ID: 8335285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac action of KB-944, a new calcium antagonist.
    Morita T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1053-5. PubMed ID: 6890825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.